← Back to Clinical Trials
Recruiting NCT07440771

NCT07440771 Effects of Traditional Game in School Going Children

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07440771
Status Recruiting
Phase
Sponsor Riphah International University
Condition Child, Only
Study Type INTERVENTIONAL
Enrollment 48 participants
Start Date 2026-02-04
Primary Completion 2026-06-30

Eligibility & Interventions

Sex All sexes
Min Age 8 Years
Max Age 12 Years
Study Type INTERVENTIONAL
Interventions
KH0-KHO gamefree play activity

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 48 participants in total. It began in 2026-02-04 with a primary completion date of 2026-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This randomized controlled trial examines whether regular participation in the traditional game \*\*Kho-Kho\*\* improves agility and reaction time in school-aged children. Due to limited physical education in schools, many children fail to achieve recommended daily physical activity, leading to physical and mental health issues. The study will involve \*\*48 children (8-12 years)\*\* from selected schools in Sialkot, divided into an experimental group (Kho-Kho) and a control group (free play). The intervention will be conducted \*\*3 times per week for 6 weeks\*\*, and outcomes will be measured using the \*\*T-Test, Ruler Drop Test, and TOES\*\*. Data will be analyzed using \*\*SPSS v21\*\*, with ethical approval from \*\*Riphah International University, Lahore\*\*.

Eligibility Criteria

Inclusion Criteria: * 8-12 years of school-going children * Give informed consent * physically healthy and medically fit to participate in physical activity * BMI within normal-for-age range to control for physical performance variability. Exclusion Criteria: * presence of at least one of the following conditions: circulatory, respiratory and musculoskeletal diseases, neuropsychiatric disease, exercise induced anaphylaxis, morbid obesity * History of injury or surgery in the past 4 months * Currently participating in other structured sports training or agility-specific coaching program, or research procedures * Inconsistent attendance in the intervention sessions.

Contact & Investigator

Central Contact

IMRAN AMJAD

✉ imran.amjad@riphah.edu.pk

📞 9233224390125

Principal Investigator

Sadida Nisar, Ms-ppt

PRINCIPAL INVESTIGATOR

Riphah International University

Frequently Asked Questions

Who can join the NCT07440771 clinical trial?

This trial is open to participants of all sexes, aged 8 Years or older, up to 12 Years, studying Child, Only. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07440771 currently recruiting?

Yes, NCT07440771 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.

Where is the NCT07440771 trial being conducted?

This trial is being conducted at Lahore, Pakistan.

Who is sponsoring the NCT07440771 clinical trial?

NCT07440771 is sponsored by Riphah International University. The principal investigator is Sadida Nisar, Ms-ppt at Riphah International University. The trial plans to enroll 48 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology